1 / 16

Creating an artificial immune system to deal with Psuedomonas aeruginosa’s biofilm

Creating an artificial immune system to deal with Psuedomonas aeruginosa’s biofilm. Mark Ly, Fahima Nakitende , Shannon Wesley. Human cystic fibrosis . Recessive genetic disorder Excess secretion Mucous Sweat Bacterial infection Pseudomonas aeruginosa.

maura
Download Presentation

Creating an artificial immune system to deal with Psuedomonas aeruginosa’s biofilm

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Creating an artificial immune system to deal with Psuedomonasaeruginosa’sbiofilm Mark Ly, FahimaNakitende, Shannon Wesley

  2. Human cystic fibrosis • Recessive genetic disorder • Excess secretion • Mucous • Sweat • Bacterial infection • Pseudomonas aeruginosa Fig. 1. Age distribution of the Canadian CF population for 2008.

  3. Psuedomonasaeruginosa • Protective slime layer • 200μm thick • Transport • Antibiotic resistance • Genetic mutation • Accumulation of environmental genes Fig. 2. Biofilm formation

  4. Nanowire bundles Wires with a diameter in the nanometer scale A group of nanowires Conductive Large surface area Used as detectors inbioelectrochemistry Fig. 3. Transmission electron microscopy of Cu(OH)2 nanowires (Zhuang et al. 2007) Fig. 4. Image of ordered nanowire in a microarray.

  5. Research Question • Develop a new method to treat biofilms using nanowire bundles • Can copper oxide nanowires carrying antibiotics diffuse through the porous strucuture of Pseudomonas aeruginosa’sbiofilm?

  6. Why copper oxide • Copper was one of the effective metals in previous experiments • Works well in biological settings from glucose and hemoglobin experiments.

  7. Proposed experiment: Artificial neutriphil net Emulate our immune system with nanowire bundles couple with antibiotics:Ciprofloxacin and Tobramycin Use this net on biofilms to get through the slime layer more effectively. Fig. 5. Image of a neutriphil net trapping bacteria

  8. Methods Biofilm Nanowire synthesis Following experimental design done by Li et al. Self assembled nanowire bundles • Following the experimental design done by Harrison et al. • Use of high throughput MBEC assay • Degrade

  9. Expected results • We expect to see no growth if the antibiotics are able to penetrate the biofilm layer effectively

  10. Previous studies on Pseudomonas aeruginosa Use of Heavy metals Use of antibiotics Use of Ciprofloxacin and Tobramycin antibiotics (Walters et al., 2003) Slow diffusion of tobramycin due to binding Ciprofloxacin ineffective Oxygen may be limiting factor. Metal cations (Harrison et al., 2005) Cobalt, copper, nickel, silver. • Need high concentrations of metal cations to kill populations • Persister cells are killed at a slower rate

  11. Drawbacks of metal cations High concentrations needed Long continuous exposure time Fig. 6. Log killing of biofilm cultures with increasing concentration of Copper ions over a 27 hour period. (Harrison et al., 2005).

  12. Why the antibiotics didn’t work Tobramycin slower than ciprofloxacin Lack of oxygen restricts bacterial metabolic activity Took long to penetrate through the biofilm Fig. 7. Penetration of tobramycin (squares) and ciprofloxacin (circles) in P. aeruginosa. Open symbols are in sterile controls (Walters et al., 2003)

  13. Ineffective antibiotic experiment Ciprofloxacin Tobramycin Time (h) Fig. 8. Killing of P. aeruginosain biofilms in exposure to ciprofloxacin. Filled squares were the treatment and the unfilled were the controls (Walter et al.) Fig. 9. Killing of P. aeruginosain biofilms in exposure to tobramycin. Filled squares were the treatment and the unfilled were the controls.

  14. Types of antibiotics used Ciprofloxacin Tobramycin

  15. Literature cited • Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. 1999. The Calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. Journal of Clinical Microbiology. 37:1771-1776. • Hanlon WG, Denyer Ps, Olliff JC, Ibrahim JL. 2001. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosabiofilms. American Society for Microbiology. 67: 2746-53. • Harrison JJ, Turner RJ, Ceri H. 2005. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Biofilm Research Group. University of Calgary. 7: 981-94. • Li Y, Zhang Q, Li J. 2010. Direct electrochemistry of hemoglobin immobilized in CuOnanowire bundles. Talanta. 83: 162-66. • Walters CM, Roe F, Bugnicourt A, Franklin MJ, Stewart SP. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosabiofilms to ciprofloxacin and tobramyacin. American Society for Microbiology. 47: 317-23. • Canadian Cystic Fibrosis Foundation. 2008. Canadian cystic fibrosis patient data registry report. Pg: 11,24.

  16. Take home message • Interdisciplinary aspects • Pseudomonas aeruginosamost common and increasing • Possible other applications Fig. 10. Comparative percentage of the types of bacterial infections in CF patients in 2007 and 2008.

More Related